date,title,source
Oct-22-18,Theravance Biopharma Reports Data from TD-1473 Phase 1b Four-Week Study in Oral Late-Breaker Presentation at UEG Week 2018,PR Newswire
Oct-30-18,Theravance Biopharma (TBPH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release,Zacks
Oct-30-18,Theravance Biopharma to Report Third Quarter 2018 Financial Results on November 6,PR Newswire
Nov-06-18,"Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-06-18,Theravance Bio: 3Q Earnings Snapshot,Associated Press
Nov-06-18,"Theravance Biopharma, Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update",PR Newswire
Nov-07-18,Theravance Biopharma to Present at the Credit Suisse 27th Annual Healthcare Conference,PR Newswire
Nov-07-18,Edited Transcript of TBPH earnings conference call or presentation 6-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Nov-08-18,"Theravance (TBPH) Beats on Q3 Earnings, Inks Deal for Vibativ",Zacks
Nov-09-18,Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease,PR Newswire
Nov-09-18,Mylan and Theravance Biopharma's COPD treatment gets FDA approval,Reuters
Nov-12-18,"Health Care Digest: A big Berkeley bio incubator, Apple's clinical trial help and more",American City Business Journals
Nov-12-18,Theravance Biopharma Highlights Expanded COPD Indication for Trelegy Ellipta in Europe,PR Newswire
Nov-14-18,"New Research Coverage Highlights Nexa Resources S.A, Qumu, Clearway Energy, Vermillion, Cantel Medical, and Theravance Biopharma  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
